Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 57, Issue 1, 2004, Pages 93-99

  Zerrouk, Naima ^a   Mennini, Natascia ^b   Maestrelli, Francesca ^b   Chemtob, Chantal ^a   Mura, Paola ^b  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Analgesic effect; Chitosan; Cogrinding; Dissolution; Naproxen; Polyvinylpyrrolidone

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; ANTIULCER AGENT; CHITOSAN; DRUG CARRIER; NAPROXEN; POVIDONE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DOSAGE FORM; DRUG POTENCY; DRUG RELEASE; DRUG SOLUBILITY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SOLID STATE; WRITHING TEST; X RAY DIFFRACTION;

EID: 0346094166     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(03)00112-7     Document Type: Article

References (28)

1. Felt O., Buri P., Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:1998;979-993.
2. Dodane V., Vilivalam V.D. Pharmaceutical applications of chitosan. Pharm. Sci. Technol. Today. 1:1998;246-253.
3. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1998;1326-1331.
4. th century. STP Pharma Sci. 10:2000;5-22.
5. Nagai T., Sawayanagi Y., Nambu N. Applications of chitin and chitosan to pharmaceutical preparations. Zizakis J.P. Chitin, Chitosan and Related Enzymes. 1984;21-39 Academic Press, Orlando, FL.
6. Ritthidej G.C., Chomto P., Pummangura S., Menasveta P. Chitin and Chitosan as disintegrants in paracetamol tablets. Drug Dev. Ind. Pharm. 20:1994;2109-2134.
7. Upadrashta S.M., Katikaneni P.R., Nuessle N.O. Chitosan as a tablet binder. Drug Dev. Ind. Pharm. 18:1992;1701-1708.
8. Genta I., Conti B., Perugini P., Pavanetto F., Spadaro A., Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharm. Pharmacol. 49:1997;737-742.
9. Schippern G., Olsson S., Hoogstraate J.A., Deboer A.G., Varum K.M., Artursson P. Chitosan as absorption enhancers for poorly absorbable drugs. Pharm. Res. 14:1997;923-929.
10. Bernkop-Schnurch A., Pasta M. Intestinal peptide and protein delivery: novel bioadhesive drug-carrier matrix shielding from enzymatic attack. J. Pharm. Sci. 87:1998;430-434.
11. Bugamelli F., Raggi M.A., Orienti I., Zecchi V. Controlled insulin release from chitosan microparticles. Arch. Pharm. 331:1998;58-65.
12. Vandamme T.F., Lenourry A., Charrueau C., Chaumeil J.C. The use of polysaccharides to target drugs to the colon. Carbohydr. Polym. 48:2002;219-231.
13. Sawayanagi Y., Nambu N., Nagai T. Dissolution properties and bioavailability of phenytoin from ground mixtures with chitin or chitosan. Chem. Pharm. Bull. 31:1983;2062-2068.
14. Shiraishi S., Arahira M., Imai T., Otagiri M. Enhancement of dissolution rates of several drugs by low molecular chitosan and alginate. Chem. Pharm. Bull. 38:1990;185-187.
15. Acarturk F., Sencan A., Celebi N. Evaluation of the effect of low molecular weight chitosan on the solubility and dissolution characteristics of spironolactone. Pharmazie. 48:1993;605-607.
16. Portero A., Remuñan-Lopez C., Vila-Jato J.L. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int. J. Pharm. 175:1998;75-84.
17. Hillyard I.W., Doczi J., Kiernan P.B. Antiacid and antiulcer properties of the polysaccharide chitosan. Proc. Soc. Exp. Biol. Med. 115:1964;1108-1112.
18. Houw M., Miyazaki S., Takada M., Komai T. Sustained release of indomethacin from chitosan granules. Chem. Pharm. Bull. 33:1985;3986-3992.
19. Açikgoz M., Kas H.S., Hasçelik Z., Milli U., Hincal A.A. Chitosan microspheres of diclophenac sodium. II: In vitro and in vivo evaluation. Pharmazie. 50:1995;275-277.
20. Mura P., Zerrouk N., Faucci M.T., Mennini N., Chemtob C. Effect of chitosan on dissolution properties of naproxen. Barratt G., Duchêne D., Fattal F., Legendre J.Y. New Trends in Polymers for Oral and Parenteral Administration: From Design to Receptors. 2001;192-195 Editions de Santé Paris.
21. Bettinetti G.P., Mura P. Dissolution properties of naproxen in combinations with polyvinylpyrrolidone. Drug Dev. Ind. Pharm. 20:1994;1353-1366.
22. Nogami H., Nagai T., Yotsuyanagi I. Dissolution phenomena of organic medicinals involving simultaneous phase changes. Chem. Pharm. Bull. 17:1969;499-509.
23. Khan K.A. The concept of dissolution efficiency. J. Pharm. Pharmac. 27:1975;48-49.
24. Inoue K., Fujisawa H., Motonaga A., Inoue Y., Kyoi T., Ueda F., Kimura K. Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs. Biol. Pharm. Bull. 17:1994;1577-1583.
25. Bettinetti G.P., Mura P., Giordano F., Setti M. Thermal behaviour and physico-chemical properties of naproxen in mixtures with polyvinylpyrrolidone. Thermochim. Acta. 199:1991;165-171.
26. Bettinetti G.P., Mura P., Liguori A., Bramanti G., Giordano F. Solubilization and interaction of naproxen with polyvinylpyrrolidone in aqueous solution and in the solid state. Farmaco Ed. Prat. 43:1988;331-343.
27. Nakai Y. Molecular behavior of medicinals in ground mixtures with microcrystalline cellulose and cyclodextrins. Drug Dev. Ind. Pharm. 12:1986;1017-1039.
28. Price D., Mao J., Lu J., Caruso F.S., Frenk H., Mayer D.I. Effects of the combined oral administration of NSAIDs and dextramethorphan on behavioral symptoms indicative of arthritic pain in rats. Int. J. Pharm. 68:1996;119-127.